Common Infections — MCQs
On this page
According to current UK antimicrobial guidance, what is the first-line empirical antibiotic for treatment of uncomplicated cellulitis in a patient with no drug allergies?
A 58-year-old man with well-controlled HIV (CD4 count 450 cells/μL, undetectable viral load) presents with a 10-day history of multiple painful ulcers on his lower legs. The ulcers have violaceous, undermined borders and purulent bases. He has a history of ulcerative colitis. Swabs grow mixed skin flora. What is the most appropriate next step in management?
A 32-year-old woman with no significant past medical history presents with a 4-day history of a painful, red, swollen area on her left breast. She is 6 weeks postpartum and breastfeeding. Examination reveals a 5 cm area of erythema and induration in the upper outer quadrant of the left breast. Temperature is 38.2°C. There is no fluctuance. What is the most appropriate initial management?
A hospital trust implements a new antimicrobial stewardship policy requiring indication and planned duration to be documented for all antimicrobial prescriptions. Six months post-implementation, audit data shows documentation rates have increased from 35% to 88%. However, antimicrobial consumption (measured in defined daily doses per 1000 patient-bed days) remains unchanged. What does this finding suggest?
A 69-year-old man with peripheral vascular disease and atrial fibrillation on warfarin presents with cellulitis of his right lower leg. Blood cultures are pending. He has a documented severe penicillin allergy (anaphylaxis). His INR is 2.8. Which antibiotic regimen is most appropriate for initial empirical therapy?
A 38-year-old woman presents with a 5-day history of painful bilateral shin lesions. She has been feeling unwell for 2 weeks with a sore throat and low-grade fever. Examination reveals multiple tender, raised, erythematous nodules on both shins without ulceration. Chest X-ray shows bilateral hilar lymphadenopathy. What is the most likely diagnosis?
A 47-year-old man who is a fish tank enthusiast presents with a 3-week history of a slowly progressive papulonodular lesion on his right index finger following a minor injury while cleaning his aquarium. The lesion has a violaceous appearance with superficial ulceration. He is systemically well. What is the most appropriate antimicrobial treatment?
A hospital antimicrobial stewardship committee is implementing a new intervention to reduce inappropriate antimicrobial use. Data shows that the average duration of intravenous antibiotics for community-acquired pneumonia is 6.2 days despite most patients meeting criteria for IV to oral switch by day 3. What intervention is most likely to achieve sustained reduction in IV antibiotic duration?
A 55-year-old woman with chronic lymphocytic leukaemia on ibrutinib presents with a 48-hour history of a rapidly expanding painful lesion on her right forearm following a cat scratch. Examination reveals a 6 cm area of erythema with central necrosis and violaceous bullae. Temperature is 38.7°C, BP 110/70 mmHg, HR 105 bpm. Which organism is most likely responsible for this presentation?
According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the recommended timeframe for reviewing all antimicrobial prescriptions after initiation to assess the need for continuation, modification, or cessation?
Common Infections UK Medical PG Practice Questions and MCQs
Question 131: According to current UK antimicrobial guidance, what is the first-line empirical antibiotic for treatment of uncomplicated cellulitis in a patient with no drug allergies?
- A. Oral flucloxacillin (Correct Answer)
- B. Oral co-amoxiclav
- C. Oral clarithromycin
- D. Intravenous benzylpenicillin
- E. Oral doxycycline
Explanation: ***Oral flucloxacillin*** - **Flucloxacillin** is the recommended first-line agent for uncomplicated cellulitis because it provides excellent coverage against **Staphylococcus aureus** and **Streptococcus pyogenes**. - It has high **oral bioavailability** and a targeted spectrum, making it the most appropriate choice for patients with no known drug allergies. *Oral co-amoxiclav* - This provides unnecessarily broad coverage against anaerobic and Gram-negative organisms, which is not required for **uncomplicated cellulitis**. - It is typically reserved for cellulitis following **animal bites** or facial involvement where different pathogens are suspected. *Oral clarithromycin* - This is a macrolide usually reserved as a second-line option for patients with a **penicillin allergy**. - It is not first-line because **flucloxacillin** is superior in its narrow-spectrum targeting of skin flora in non-allergic patients. *Intravenous benzylpenicillin* - **Benzylpenicillin** has poor activity against **Staphylococcus aureus** and is primarily effective against Streptococci, making it insufficient as mono-therapy for cellulitis. - The **intravenous route** is inappropriate for uncomplicated cases that can be managed effectively with oral outpatient treatment. *Oral doxycycline* - **Doxycycline** is considered an alternative treatment for patients with a **penicillin allergy** or when **MRSA** is a specific concern. - It is not the preferred first-line agent for common **Staphylococcal** or **Streptococcal** skin infections in the general population.
Question 132: A 58-year-old man with well-controlled HIV (CD4 count 450 cells/μL, undetectable viral load) presents with a 10-day history of multiple painful ulcers on his lower legs. The ulcers have violaceous, undermined borders and purulent bases. He has a history of ulcerative colitis. Swabs grow mixed skin flora. What is the most appropriate next step in management?
- A. Start intravenous flucloxacillin and metronidazole
- B. Arrange skin biopsy to exclude vasculitis or malignancy
- C. Start high-dose oral prednisolone
- D. Refer to dermatology for consideration of pyoderma gangrenosum (Correct Answer)
- E. Perform wound debridement and arrange tissue culture
Explanation: ***Refer to dermatology for consideration of pyoderma gangrenosum*** - The presence of multiple painful ulcers with **violaceous, undermined borders** and **purulent bases**, combined with a history of **ulcerative colitis**, is highly characteristic of **pyoderma gangrenosum (PG)**. - PG is a **neutrophilic dermatosis** and an inflammatory condition, not a primary infection, requiring specialized dermatological expertise for accurate diagnosis and management with immunosuppressive therapy. *Start intravenous flucloxacillin and metronidazole* - The growth of **mixed skin flora** from swabs suggests colonization of the ulcers rather than an active, primary bacterial infection that would necessitate systemic antibiotics. - PG is an **auto-inflammatory** condition, and antibiotics are generally ineffective in addressing its underlying pathophysiology. *Arrange skin biopsy to exclude vasculitis or malignancy* - While biopsy can be considered, **pyoderma gangrenosum is a diagnosis of exclusion**, and the biopsy site itself can be subject to **pathergy**, where trauma causes the ulcer to worsen or expand. - A specialist consultation is crucial to guide the diagnostic process, including the timing and necessity of a biopsy, to avoid exacerbating the condition. *Start high-dose oral prednisolone* - Although **systemic corticosteroids** are a cornerstone of PG treatment, initiating such potent therapy without a definitive diagnosis by a specialist can mask other conditions. - High-dose steroid use in an **HIV-positive patient**, even with a well-controlled viral load, requires careful consideration and coordinated care between dermatology and infectious disease specialists. *Perform wound debridement and arrange tissue culture* - **Surgical debridement is strictly contraindicated** in suspected pyoderma gangrenosum due to the phenomenon of **pathergy**, which leads to the enlargement and worsening of the ulcers with any traumatic intervention. - Tissue culture would likely confirm the presence of commensal flora, similar to the swabs, and would not address the inflammatory nature of the lesions.
Question 133: A 32-year-old woman with no significant past medical history presents with a 4-day history of a painful, red, swollen area on her left breast. She is 6 weeks postpartum and breastfeeding. Examination reveals a 5 cm area of erythema and induration in the upper outer quadrant of the left breast. Temperature is 38.2°C. There is no fluctuance. What is the most appropriate initial management?
- A. Advise to stop breastfeeding and prescribe oral flucloxacillin
- B. Continue breastfeeding and prescribe oral flucloxacillin (Correct Answer)
- C. Arrange urgent ultrasound of the breast before starting antibiotics
- D. Continue breastfeeding, prescribe oral co-amoxiclav and regular breast massage
- E. Refer urgently to breast surgery for incision and drainage
Explanation: ***Continue breastfeeding and prescribe oral flucloxacillin***- **Lactational mastitis** is most commonly caused by **Staphylococcus aureus**, and **flucloxacillin** is the first-line antibiotic treatment as it is safe during breastfeeding.- Maintaining **milk drainage** by continuing breastfeeding or expression is essential to resolve **milk stasis** and prevent the progression to a breast abscess.*Advise to stop breastfeeding and prescribe oral flucloxacillin*- Stopping breastfeeding is contraindicated as it promotes **milk stasis**, which significantly increases the risk of **abscess formation**.- Emptying the breast is a critical component of treatment to help clear the **bacterial load** and inflammatory debris.*Arrange urgent ultrasound of the breast before starting antibiotics*- Clinical diagnosis of mastitis is sufficient for starting antibiotics; an **ultrasound** is only indicated if an **abscess** is suspected due to **fluctuance** or failure to respond to treatment.- Delaying antibiotics in the presence of **systemic symptoms** like fever (38.2°C) can lead to worsening infection.*Continue breastfeeding, prescribe oral co-amoxiclav and regular breast massage*- **Flucloxacillin** is preferred over **co-amoxiclav** because it specifically targets the commonest pathogen, **Staph. aureus**, without providing unnecessary broad-spectrum coverage.- While breastfeeding and massage are helpful, **co-amoxiclav** is usually reserved for second-line treatment or suspected anaerobic involvement.*Refer urgently to breast surgery for incision and drainage*- Surgical intervention is only required for a **breast abscess**, which is typically characterized by **fluctuance** on examination.- This patient presents with **induration** only, which is characteristic of cellulitis of the breast tissue and should be managed medically first.
Question 134: A hospital trust implements a new antimicrobial stewardship policy requiring indication and planned duration to be documented for all antimicrobial prescriptions. Six months post-implementation, audit data shows documentation rates have increased from 35% to 88%. However, antimicrobial consumption (measured in defined daily doses per 1000 patient-bed days) remains unchanged. What does this finding suggest?
- A. The intervention has failed and should be discontinued
- B. Documentation alone is insufficient to change prescribing behavior without active review and feedback (Correct Answer)
- C. The antimicrobial consumption was already optimal before the intervention
- D. The audit methodology is flawed and cannot detect changes in consumption
- E. Six months is too short a period to detect changes in antimicrobial consumption
Explanation: ***Documentation alone is insufficient to change prescribing behavior without active review and feedback*** - Passive interventions like documentation of indication improve **accountability and process measures** but do not directly challenge the clinical decision-making involved in antimicrobial use. - Effective antimicrobial stewardship requires **active interventions**, such as prospective audit and feedback or clinical pharmacist review, to translate documentation into actual **consumption reduction**. *The intervention has failed and should be discontinued* - The intervention successfully achieved its primary process goal of increasing **documentation rates** from 35% to 88%, which provides a better baseline for future audits. - Rather than discontinuation, this stage indicates a need to **evolve the strategy** by adding active clinical reviews to the existing documentation framework. *The antimicrobial consumption was already optimal before the intervention* - A documentation rate of 35% historically correlates with **suboptimal prescribing habits**, and a lack of change in DDDs suggests substantial **opportunities for optimization** remain. - Achieving "optimal" consumption usually results in a shift toward **narrow-spectrum agents**, which would still reflect a change in specific consumption metrics not seen here. *The audit methodology is flawed and cannot detect changes in consumption* - **Defined Daily Dose (DDD)** per 1000 patient-bed days is a standardized global metric that is highly sensitive to changes in total antimicrobial volume. - The methodology successfully detected a change in **process measures** (documentation); the lack of change in consumption is a result of prescribing behavior, not a measurement failure. *Six months is too short a period to detect changes in antimicrobial consumption* - Six months provides **sufficient time** for prescription cycles to turn over and for changes in hospital-wide prescribing patterns to manifest in the data. - Stewardship interventions that include **active feedback** typically show significant reductions in consumption within three to six months of implementation.
Question 135: A 69-year-old man with peripheral vascular disease and atrial fibrillation on warfarin presents with cellulitis of his right lower leg. Blood cultures are pending. He has a documented severe penicillin allergy (anaphylaxis). His INR is 2.8. Which antibiotic regimen is most appropriate for initial empirical therapy?
- A. Intravenous clindamycin
- B. Intravenous teicoplanin (Correct Answer)
- C. Intravenous meropenem
- D. Oral doxycycline
- E. Intravenous clarithromycin
Explanation: ***Intravenous teicoplanin*** - **Teicoplanin** is a **glycopeptide** with excellent activity against **Group A Streptococcus** and **Staphylococcus aureus**, the most common causes of cellulitis, and is suitable for systemic therapy in this setting. - It is safe for patients with **anaphylactic penicillin allergy** as it lacks cross-reactivity with beta-lactams and does not significantly interact with **warfarin**, making it a suitable choice for a patient with an INR of 2.8. *Intravenous clindamycin* - While effective against Gram-positives, **clindamycin** can significantly increase the **INR/warfarin effect** by inhibiting CYP enzymes, posing a bleeding risk for a patient already on warfarin. - There are increasing rates of **resistance** among staphylococci and streptococci, making it less reliable for empirical monotherapy in severe cases like this. *Intravenous meropenem* - **Meropenem** is a **carbapenem** and carries a **1-2% cross-reactivity risk** in patients with documented **penicillin anaphylaxis**, making it contraindicated due to the severe allergy history. - It provides unnecessarily broad coverage (including Gram-negatives and anaerobes) for a typical case of simple **cellulitis**, where targeted Gram-positive coverage is usually sufficient. *Oral doxycycline* - **Oral doxycycline** is generally reserved for **mild cellulitis** or as part of a step-down regimen; intravenous therapy is indicated for a patient with risk factors like peripheral vascular disease and requiring hospital admission. - It has inconsistent or poor activity against **Group A Streptococcus**, which is a primary pathogen in rapidly spreading skin infections and would not be appropriate as initial monotherapy for severe cellulitis. *Intravenous clarithromycin* - **Clarithromycin** is a macrolide that frequently interacts with **warfarin** via CYP3A4 inhibition, leading to a dangerous rise in **prothrombin time/INR**, similar to clindamycin, and is thus unsuitable for this patient. - Resistance among common skin pathogens is a concern, and it is not considered first-line for **severe cellulitis** compared to glycopeptides, especially with a severe penicillin allergy.
Question 136: A 38-year-old woman presents with a 5-day history of painful bilateral shin lesions. She has been feeling unwell for 2 weeks with a sore throat and low-grade fever. Examination reveals multiple tender, raised, erythematous nodules on both shins without ulceration. Chest X-ray shows bilateral hilar lymphadenopathy. What is the most likely diagnosis?
- A. Erysipelas
- B. Cellulitis
- C. Erythema nodosum secondary to sarcoidosis (Correct Answer)
- D. Necrotizing fasciitis
- E. Pyoderma gangrenosum
Explanation: ***Erythema nodosum secondary to sarcoidosis***- The presentation of **tender, erythematous nodules** on the shins, systemic symptoms like **sore throat** and **low-grade fever**, and crucially, **bilateral hilar lymphadenopathy (BHL)** on chest X-ray, is pathognomonic for **Löfgren's syndrome**, an acute manifestation of sarcoidosis.- Erythema nodosum is a form of **septal panniculitis** that typically presents as non-ulcerated, painful nodules on the extensor surfaces of the lower legs, often triggered by various conditions including sarcoidosis.*Erysipelas*- This is a superficial cutaneous infection characterized by a **well-demarcated**, raised, and fiery red plaque, which is usually **unilateral** and caused by bacterial pathogens.- It does not typically involve **bilateral hilar lymphadenopathy** or present as multiple discrete nodules.*Cellulitis*- Cellulitis involves deeper dermis and subcutaneous fat, presenting as an **ill-defined, unilateral** area of warmth and erythema, rather than discrete nodules.- It is an acute bacterial infection that lacks the characteristic **distribution** and radiological findings (BHL) of sarcoidosis.*Necrotizing fasciitis*- This is a surgical emergency characterized by **rapidly progressing** tissue destruction, severe systemic toxicity, and "pain out of proportion" to clinical findings.- It typically features **crepitus**, skin necrosis, or hemorrhagic bullae, which are absent in this patient who presents with non-ulcerating nodules.*Pyoderma gangrenosum*- This condition presents as a rapidly enlarging, **painful ulcer** with a **purulent base** and **violaceous, undermined borders**, often associated with inflammatory bowel disease.- The lesions in this patient are described as **non-ulcerating nodules**, which differentiates them from the typical ulcerative progression of pyoderma gangrenosum.
Question 137: A 47-year-old man who is a fish tank enthusiast presents with a 3-week history of a slowly progressive papulonodular lesion on his right index finger following a minor injury while cleaning his aquarium. The lesion has a violaceous appearance with superficial ulceration. He is systemically well. What is the most appropriate antimicrobial treatment?
- A. Flucloxacillin 500mg four times daily for 7 days
- B. Clarithromycin 500mg twice daily for 4-6 weeks (Correct Answer)
- C. Co-amoxiclav 625mg three times daily for 2 weeks
- D. Doxycycline 100mg twice daily for 2 weeks
- E. Ciprofloxacin 500mg twice daily for 10 days
Explanation: ***Clarithromycin 500mg twice daily for 4-6 weeks***- The clinical presentation with a **slowly progressive papulonodular lesion** on the hand of a **fish tank enthusiast** following an injury is highly characteristic of **Mycobacterium marinum** infection, often called "fish tank granuloma."- **Clarithromycin** is a recommended first-line agent for *M. marinum* infections, and a prolonged treatment course of **4-6 weeks** (or even longer, typically until 1-2 months after lesion resolution) is necessary due to the slow-growing nature of **atypical mycobacteria**.*Flucloxacillin 500mg four times daily for 7 days*- This antibiotic is primarily used for **Gram-positive bacterial infections** like *Staphylococcus aureus* or *Streptococcus pyogenes*, common causes of acute cellulitis or skin abscesses.- Flucloxacillin is ineffective against **Mycobacterium marinum**, and the 7-day duration is far too short for **mycobacterial infections**, which require prolonged therapy.*Co-amoxiclav 625mg three times daily for 2 weeks*- Co-amoxiclav is a broad-spectrum antibiotic effective against many common bacterial skin pathogens, including some anaerobes, but it does not cover **atypical mycobacteria** like *M. marinum*.- A 2-week course is insufficient for **mycobacterial infections**, which typically demand treatment durations of several weeks to months for successful eradication.*Doxycycline 100mg twice daily for 2 weeks*- While **Doxycycline** is an effective agent against **Mycobacterium marinum**, often used as a first-line or alternative therapy, the specified **2-week duration** is inadequate.- Treatment with tetracyclines like doxycycline for *M. marinum* typically requires a minimum of **3 to 6 months** or until 1-2 months after the lesion has fully resolved to prevent recurrence.*Ciprofloxacin 500mg twice daily for 10 days*- While some fluoroquinolones like **Ciprofloxacin** may show *in vitro* activity against *M. marinum*, they are generally not considered first-line monotherapy, particularly for cutaneous infections.- The **10-day course** is drastically too short for a **granulomatous mycobacterial skin infection**, which necessitates prolonged treatment.
Question 138: A hospital antimicrobial stewardship committee is implementing a new intervention to reduce inappropriate antimicrobial use. Data shows that the average duration of intravenous antibiotics for community-acquired pneumonia is 6.2 days despite most patients meeting criteria for IV to oral switch by day 3. What intervention is most likely to achieve sustained reduction in IV antibiotic duration?
- A. Monthly email reminders to all prescribers about switching guidelines
- B. Automatic stop orders for all IV antibiotics after 72 hours
- C. Implementation of a daily multidisciplinary antimicrobial ward round with real-time feedback (Correct Answer)
- D. Annual mandatory e-learning module on IV to oral switching
- E. Poster campaigns in clinical areas highlighting switch criteria
Explanation: ***Implementation of a daily multidisciplinary antimicrobial ward round with real-time feedback*** - This approach utilizes **prospective audit and feedback**, which is one of the most effective and **sustained interventions** in antimicrobial stewardship for changing clinician behavior. - Providing **point-of-care education** and direct engagement with the clinical team allows for nuanced decision-making while consistently reinforcing **IV-to-oral switch** guidelines. *Monthly email reminders to all prescribers about switching guidelines* - This is considered a **passive intervention**, which has limited impact on long-term clinical practice and often suffers from **information overload**. - Educational materials without **active engagement** or specific patient-level feedback are rarely effective in achieving significant reductions in antibiotic duration. *Automatic stop orders for all IV antibiotics after 72 hours* - While this creates a hard stop, it can be **clinically unsafe** as it may interrupt critical treatment for complex patients who genuinely require extended IV therapy. - Such systems often lead to **work-around behaviors**, such as clinicians reflexively renewing orders without a proper clinical review, defeating the purpose of the intervention. *Annual mandatory e-learning module on IV to oral switching* - One-time or infrequent **educational modules** lack the real-time reinforcement necessary to alter daily prescribing habits in a dynamic hospital environment. - **Knowledge acquisition** through e-learning does not consistently translate into permanent clinical **behavioral change** compared to daily clinical bedside practice. *Poster campaigns in clinical areas highlighting switch criteria* - Visual aids and posters are **passive alerts** that are easily ignored by busy clinical staff and do not provide the necessary drive for clinical action. - These tools are best used as **adjuncts** to active strategies rather than standalone interventions for achieving a sustained reduction in antibiotic use.
Question 139: A 55-year-old woman with chronic lymphocytic leukaemia on ibrutinib presents with a 48-hour history of a rapidly expanding painful lesion on her right forearm following a cat scratch. Examination reveals a 6 cm area of erythema with central necrosis and violaceous bullae. Temperature is 38.7°C, BP 110/70 mmHg, HR 105 bpm. Which organism is most likely responsible for this presentation?
- A. Pasteurella multocida (Correct Answer)
- B. Capnocytophaga canimorsus
- C. Bartonella henselae
- D. Streptococcus pyogenes
- E. Staphylococcus aureus
Explanation: ***Pasteurella multocida*** - **Pasteurella multocida** is a commensal in the oral cavity of cats and is the most common organism isolated from infections following **cat scratches or bites**, especially with rapid onset. - This pathogen is known for its **rapid clinical progression** (often within 24-48 hours) and can cause severe, necrotic cellulitis with **erythema, central necrosis, and violaceous bullae**, particularly in **immunocompromised** patients like those with CLL on ibrutinib. *Capnocytophaga canimorsus* - While it can cause severe sepsis and skin necrosis in immunocompromised hosts, it is much more frequently associated with **dog bites** rather than cat scratches. - The clinical presentation usually features overwhelming **sepsis or meningitis** rather than a localized rapidly expanding necrotizing skin lesion within 48 hours of a scratch. *Bartonella henselae* - This organism is the causative agent of **Cat Scratch Disease**, which typically presents with a subacute course involving **regional lymphadenopathy** weeks after a scratch. - It does not present as an acute, **rapidly expanding necrotizing lesion** with systemic toxicity and violaceous bullae as seen in this localized cellulitis case. *Streptococcus pyogenes* - While a common cause of **necrotizing fasciitis** and cellulitis, it is less specifically associated with the initial inoculation event of a **feline scratch** compared to a zoonotic organism. - The rapid onset immediately following feline contact makes a pathogen directly linked to animal oral flora a more statistically likely primary driver of the infection. *Staphylococcus aureus* - **Staphylococcus aureus** typically presents with a more localized, purulent infection or **abscess formation** rather than the rapid, widespread erythema with central necrosis and violaceous bullae described. - Like Streptococcus, while it can complicate skin trauma, it lacks the specific **epidemiological link** to feline oral flora that defines the high-risk period immediately following a cat scratch.
Question 140: According to the UK 'Start Smart - Then Focus' antimicrobial stewardship toolkit, what is the recommended timeframe for reviewing all antimicrobial prescriptions after initiation to assess the need for continuation, modification, or cessation?
- A. Within 24 hours of initiation
- B. Within 48-72 hours of initiation (Correct Answer)
- C. Within 5 days of initiation
- D. Within 7 days of initiation
- E. At the end of the prescribed course
Explanation: ***Within 48-72 hours of initiation*** - The UK **'Start Smart - Then Focus'** toolkit mandates a clinical review at **48-72 hours** to make a clear decision: stop, switch to oral, change (de-escalate/escalate), or continue. - This timeframe is critical as **microbiology results** and the patient's initial clinical response are typically available, allowing for more targeted therapy. *Within 24 hours of initiation* - While early review is beneficial, 24 hours is often **too soon** for definitive culture results or to observe a full clinical response to antibiotics. - The toolkit emphasizes the **second phase ('Then Focus')** specifically starting at the 48-hour mark to ensure data-driven decisions. *Within 5 days of initiation* - Waiting five days to review an antimicrobial can lead to **unnecessary broad-spectrum exposure**, increasing the risk of resistance and side effects like C. difficile. - The **five rights** (right drug, dose, etc.) should be confirmed much earlier than five days to optimize patient safety. *Within 7 days of initiation* - A seven-day review window is far beyond the **stewardship goal** of early de-escalation and prompt IV-to-oral conversion. - Delayed review at this stage is associated with **prolonged hospital stays** and inappropriate antimicrobial utilization. *At the end of the prescribed course* - Reviewing only at the end of a course fails to implement **antimicrobial stewardship**, as the opportunity to refine therapy based on clinical progress is missed. - This approach risks **over-treating** the patient and does not allow for potential cessation of ineffective or unnecessary treatment.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free